Baillie Gifford & Co’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.97K | Sell |
130
-46
| -26% | -$3.18K | ﹤0.01% | 259 |
|
|
2025
Q1 | $12.2K | Buy |
176
+123
| +232% | +$8.54K | ﹤0.01% | 259 |
|
|
2024
Q4 | $4.56K | Hold |
53
| – | – | ﹤0.01% | 267 |
|
|
2024
Q3 | $6.31K | Buy |
53
+9
| +20% | +$1.07K | ﹤0.01% | 274 |
|
|
2024
Q2 | $6.28K | Buy |
44
+18
| +69% | +$2.57K | ﹤0.01% | 280 |
|
|
2024
Q1 | $3.34K | Buy |
+26
| New | +$3.34K | ﹤0.01% | 285 |
|